The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.


Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Marco Rubio Steps Down as Acting U.S. Archivist Amid Federal Law Limits
FDA Approves Mitapivat for Anemia in Thalassemia Patients
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
NATO to Discuss Strengthening Greenland Security Amid Arctic Tensions
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday 



